Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for Capricor Therapeutics (CAPR) over the last 14 years, with Dec 2024 value amounting to -$12.3 million.

  • Capricor Therapeutics' Other Working Capital Changes rose 142.73% to $966,329 in Q3 2025 from the same period last year, while for Sep 2025 it was -$362,423, marking a year-over-year increase of 97.26%. This contributed to the annual value of -$12.3 million for FY2024, which is 286.10% down from last year.
  • Latest data reveals that Capricor Therapeutics reported Other Working Capital Changes of -$12.3 million as of FY2024, which was down 286.10% from -$3.2 million recorded in FY2023.
  • Capricor Therapeutics' 5-year Other Working Capital Changes high stood at $27.4 million for FY2022, and its period low was -$12.3 million during FY2024.
  • In the last 3 years, Capricor Therapeutics' Other Working Capital Changes had a median value of -$3.2 million in 2023 and averaged $4.0 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 18,355.52% in 2022, then slumped by 286.10% in 2024.
  • Over the past 5 years, Capricor Therapeutics' Other Working Capital Changes (Yearly) stood at $207,324 in 2020, then declined by 28.26% to $148,728 in 2021, then spiked by 18,355.52% to $27.4 million in 2022, then tumbled by 111.58% to -$3.2 million in 2023, then crashed by 286.10% to -$12.3 million in 2024.